97219 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
Sub-classes:GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE
#2GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE
#3INFLUENZA VACCINES AND METHODS OF USE THEREOF
#4Anti-hepatitis C antibodies and antigen binding fragments thereof
#5INFLUENZA VACCINES AND METHODS OF USE THEREOF
#6Humanized monoclonal antibodies and methods of use
#7HIV-1 V3 mimotopes capable of inducing cross-clade neutralizing antibodies
#8Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes
#9Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes
#10IDIOTYPIC ANTIBODIES AND USES THEREOF
#11HIV-1 V3 mimotopes capable of inducing cross-clade neutralizing antibodies
#12Idiotypic antibodies and uses thereof
#13Humanized monoclonal antibodies and methods of use
#14MIMOTOPES OF HIV ENV
#15Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes
#16Idiotypic vaccine
#17Neutralization of HCV
#18HIGH AVIDITY POLYVALENT AND POLYSPECIFIC REAGENTS
#19Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
#20Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
#21Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection